Senior Director, Oncology Indication Strategy

Bristol Myers Squibb; Princeton (NJ); On-site; USD 313,000 - 380,000; Full time

Benefits offered by this job

Flexible Time Off

Paid holidays

Vacation time

Job summary

Bristol Myers Squibb in Princeton, NJ is seeking a Senior Director, Global Clinical Development to lead clinical strategy for one or more asset indications. You will oversee a team of physicians and scientists, guiding design, execution, analysis, and interpretation of key studies.

This role requires deep therapeutic expertise, extensive leadership experience, and a track record of delivering high-quality data packages for regulatory submissions.

Qualifications

• Advanced degree in life sciences required and relevant leadership experience in clinical development.
• Deep clinical and therapeutic area expertise with drug development knowledge.
• 8+ years of experience including leadership in designing and executing multiple clinical trials.
• Proven ability to lead people in matrix or cross-functional settings.

Responsibilities

• Owns and drives clinical development strategy across asset indications, aligned to asset and disease area strategies.
• Leads a team of physicians and scientists in design, execution, analysis and interpretation of clinical studies.
• Ensures studies meet regulatory, quality, medical and access objectives and deliver high-quality data packages.
• Oversees trial progress, identifies risks, and reports status to senior management.
• Champions quality, compliance and GCP adherence across all activities.

Skills

Clinical development strategy

Team leadership

Cross-functional collaboration

Regulatory interactions

Education

Advanced degree in Life Sciences

Job description

Bristol Myers Squibb in Princeton, NJ is seeking a Senior Director, Global Clinical Development to lead clinical strategy for one or more asset indications. You will oversee a team of physicians and scientists, guiding design, execution, analysis, and interpretation of key studies.

This role requires deep therapeutic expertise, extensive leadership experience, and a track record of delivering high-quality data packages for regulatory submissions.